At #ASCO24, our #oncology team will be onsite showcasing our expanding solid tumor research and commitment to transforming cancer care. Stop by booth 23093 to learn more.
AbbVie
Arzneimittelherstellung
North Chicago, Illinois 1.362.850 Follower:innen
Info
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
Externer Link zu AbbVie
- Branche
- Arzneimittelherstellung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- North Chicago, Illinois
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics und Eye Care
Orte
Beschäftigte von AbbVie
Updates
-
NEWS: The European Medicines Agency's #CHMP granted a positive opinion for our investigational treatment in #UlcerativeColitis. Read more: https://bit.ly/4bDSiUJ #IBD [Video description: On-screen text reads, “Immunology News. Positive CHMP Opinion in Ulcerative Colitis.”]
-
Attending #ASCO24? Meet with our team of experts working to transform the standards of care for #cancer patients. Explore our career opportunities in #oncology: https://bit.ly/4bZsAtG
-
Over the past decade, new approaches and innovation have enabled scientists to reimagine #BloodCancer research – but there's more to discover. See why our scientists won’t settle when it comes to treating #cancer. https://bit.ly/3V2ggSv #WorldBloodCancerDay
-
JUST IN: We’re presenting three oral abstracts at #ASCO24 highlighting new data from our #ADC platform in #SolidTumors with high unmet needs. Read more: https://bit.ly/4bS231q [Video description: On-screen text reads, “Oncology News.”]
-
Landos Biopharma, Inc. is now part of AbbVie. This #acquisition expands our #IBD pipeline and advances our commitment to make a real difference in people’s lives. Learn more: https://bit.ly/3RlEFSn $ABBV [Video description: On-screen text reads, “Landos is now part of AbbVie" followed by the AbbVie and Landos logos.]
-
Supriya Nair, global co-chair of our Asian Leadership Network employee resource group, shares how our culture inspires her to be her most authentic self. See the difference you can make – join us: https://lnkd.in/e_RW34f7 #AAPIHM #AbbVieLife [Image description: Supriya Nair, Associate Director, Field Tools, AbbVie, says “AbbVie encourages me to be myself by fostering an environment of belonging and psychological safety, empowering me to make a positive impact through innovation, inclusiveness and authenticity.”]
-
Today marks the start of our summer #intern program. As we welcome this year’s group, hear some of our development program members’ advice for our 250+ incoming students, representing 92 universities from 30 states, supporting teams in R&D, commercial, operations and more. #AbbVieLife [Video description: Five AbbVie development program members answer the question, “What advice would you give our 2024 summer interns?”]
-
To truly understand how medications will work for people of different races, ethnicities, genders and backgrounds, #ClinicalTrials need greater diversity. Explore the bold actions we’re taking to drive greater inclusion and engage patients, caregivers and physicians in the process: https://bit.ly/4bG4u72 #ClinicalTrialsDay
-
On #ClinicalTrialsDay, we’re grateful for the researchers, investigators and patients who make our #ClinicalTrials possible. Thank you for supporting our efforts to discover future treatments and cures. Learn more: https://bit.ly/4bLYM3O [Video description: On-screen text reads, “33K+ Clinical Trial Participants; 147 Active Clinical Trial Studies; 6 Therapeutic Areas; One Big Thank You.”]
Verbundene Seiten
Ähnliche Seiten
Aktien
ABBV
NYSE
Verzögerung von 20 Minuten
161,24 USD
4,93 (3,154 %)
- Aktiv
- 156,65
- Niedrig
- 156,2
- Hoch
- 161,64
Daten von Refinitiv
Mehr Informationen aufFinanzierung
Letzte Runde
Fremdkapital nach Börsengang15.000.000.000,00 USD